IL104816A0 - Indoles - Google Patents

Indoles

Info

Publication number
IL104816A0
IL104816A0 IL104816A IL10481693A IL104816A0 IL 104816 A0 IL104816 A0 IL 104816A0 IL 104816 A IL104816 A IL 104816A IL 10481693 A IL10481693 A IL 10481693A IL 104816 A0 IL104816 A0 IL 104816A0
Authority
IL
Israel
Prior art keywords
pct
sec
preparation
date
compounds
Prior art date
Application number
IL104816A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL104816A0 publication Critical patent/IL104816A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL104816A 1992-02-28 1993-02-22 Indoles IL104816A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929204365A GB9204365D0 (en) 1992-02-28 1992-02-28 Indoles

Publications (1)

Publication Number Publication Date
IL104816A0 true IL104816A0 (en) 1993-06-10

Family

ID=10711259

Family Applications (1)

Application Number Title Priority Date Filing Date
IL104816A IL104816A0 (en) 1992-02-28 1993-02-22 Indoles

Country Status (24)

Country Link
US (1) US5767139A (fr)
EP (1) EP0628040B1 (fr)
JP (1) JP2540016B2 (fr)
KR (1) KR950700287A (fr)
CN (1) CN1079465A (fr)
AT (1) ATE164376T1 (fr)
AU (1) AU3497793A (fr)
BR (1) BR9305991A (fr)
CA (1) CA2117610C (fr)
CZ (1) CZ207794A3 (fr)
DE (1) DE69317651T2 (fr)
DK (1) DK0628040T3 (fr)
ES (1) ES2115053T3 (fr)
FI (2) FI943931A (fr)
GB (1) GB9204365D0 (fr)
HR (1) HRP930227A2 (fr)
HU (1) HUT71126A (fr)
IL (1) IL104816A0 (fr)
MX (1) MX9301112A (fr)
NO (1) NO943187L (fr)
RU (1) RU94042391A (fr)
SK (1) SK100894A3 (fr)
WO (1) WO1993017014A1 (fr)
ZA (1) ZA931383B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL109728A0 (en) * 1993-05-28 1994-08-26 Pfizer Res & Dev Indoles
ES2099007B1 (es) * 1993-07-16 1997-12-01 Pfizer Res & Dev Derivados de indol.
GB9317096D0 (en) * 1993-08-17 1993-09-29 Pfizer Ltd Indoles
GB9403516D0 (en) * 1994-02-24 1994-04-13 Pfizer Ltd Indoles
GB9409583D0 (en) * 1994-05-13 1994-07-06 Pfizer Ltd Indoles
EP0820441B1 (fr) * 1995-04-10 2002-06-26 Fujisawa Pharmaceutical Co., Ltd. Derives d'indole utilises en tant qu'inhibiteurs de cgmp-pde
WO2000007590A1 (fr) * 1998-08-03 2000-02-17 Eli Lilly And Company INHIBITEURS DE sPLA2 DE TYPE INDOLE
FR2796279B1 (fr) 1999-07-16 2001-09-21 Oreal Utilisation de l'acide 4,6-dimethoxy-indole 2-carboxylique ou de ses derives pour le traitement de la seborrhee
FR2796274B1 (fr) * 1999-07-16 2001-09-21 Oreal Utilisation de l'acide 4,6-dimethoxy-indole 2-carboxylique ou de ses derives pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
UA79504C2 (en) * 2002-11-07 2007-06-25 Organon Nv Indols for treating diseases associated with androgen receptors
KR20050072812A (ko) * 2002-11-07 2005-07-12 악조 노벨 엔.브이. 안드로겐-수용체와 관련된 질병의 치료에 효과적인 인돌
TW200602317A (en) 2004-04-23 2006-01-16 Akzo Nobel Nv Novel androgens
GB201102913D0 (en) 2011-02-18 2011-04-06 Univ Birmingham Novel therapeutic

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3557142A (en) * 1968-02-20 1971-01-19 Sterling Drug Inc 4,5,6,7-tetrahydro-indole-lower-alkanoic acids and esters
PH23498A (en) * 1984-08-06 1989-08-16 Sterling Drug Inc 3-carbonyl-1-aminoalkyl-1h-indoles,composition and use thereof
CA2036307C (fr) * 1990-03-08 2002-07-09 Susan Jean Ward Compositions anti-glaucome, a base de 3-arylcarbonyl-1-aminoalkyl-1h-indole; methode d'utilisation
GB9011335D0 (en) * 1990-05-21 1990-07-11 Fujisawa Pharmaceutical Co Indolebutyric acid derivatives and process for preparation thereof
IL109728A0 (en) * 1993-05-28 1994-08-26 Pfizer Res & Dev Indoles

Also Published As

Publication number Publication date
WO1993017014A1 (fr) 1993-09-02
JPH07500347A (ja) 1995-01-12
NO943187L (no) 1994-09-13
FI943931A0 (fi) 1994-08-26
MX9301112A (es) 1994-07-29
DK0628040T3 (da) 1998-04-27
ES2115053T3 (es) 1998-06-16
DE69317651T2 (de) 1998-07-09
CN1079465A (zh) 1993-12-15
CA2117610C (fr) 2000-07-18
CA2117610A1 (fr) 1993-09-02
FI20001771A (fi) 2000-08-09
GB9204365D0 (en) 1992-04-08
HUT71126A (en) 1995-11-28
HRP930227A2 (en) 1996-10-31
US5767139A (en) 1998-06-16
CZ207794A3 (en) 1995-01-18
FI943931A (fi) 1994-08-26
KR950700287A (ko) 1995-01-16
EP0628040B1 (fr) 1998-03-25
ATE164376T1 (de) 1998-04-15
ZA931383B (en) 1994-08-26
AU3497793A (en) 1993-09-13
HU9402466D0 (en) 1994-10-28
RU94042391A (ru) 1996-08-10
BR9305991A (pt) 1997-10-21
EP0628040A1 (fr) 1994-12-14
SK100894A3 (en) 1995-04-12
JP2540016B2 (ja) 1996-10-02
DE69317651D1 (en) 1998-04-30
NO943187D0 (no) 1994-08-29

Similar Documents

Publication Publication Date Title
IL114794A0 (en) Peptidic compounds analogous to distramycin process for their preparation and their use
SG55184A1 (en) New imidazopyridines
IL110494A0 (en) Perhydroisoindole derivatives, their preparation and pharmaceutical compositions which contain them
YU41199A (sh) Hinoksalindioni
IL104816A0 (en) Indoles
TW261614B (fr)
ZA956476B (en) N-substituted azobiccloheptane derivatives, the preparation and use thereof.
IL108288A0 (en) Pyrrolidine derivatives, their preparation and medicaments containing them
IL107520A0 (en) Substituted ortho-ethenylphenylacetic acid derivatives and pharmaceutical compositions containing them
AU3410693A (en) Carbamate derivatives and their use in medicine
TW261605B (fr)
GB9308431D0 (en) Chemical compounds
IL104049A0 (en) 7'-amino-naphthazarin antibiotic derivatives
DK0646113T3 (fr)
IL109728A0 (en) Indoles